Rupp et al. [53] reported that the epithelial cell adhesion molecules EpCAM and CD24 could be used as markers to specifically identify cancer-derived exosomes in ascites and pleural effusions from BC and ovarian cancer. This evidence concerns the gene CD24 and breast cancer.